DeSci momentum builds quietly but hits hard @BioProtocol's Ignition sales prove it with oversubs stacking real R&D capital.
@BiomeAI crunches 30k+ gut logs into personalized interventions, turning microbiome signals into on-chain health alpha. Citizen data outpaces lab silos, metabolic tweaks now verifiable and tradable.
@dogyearsdao flips pet longevity with follistatin gene therapy trials for arthritis vet nodes, owner governance, datasets proxying human aging. Cheaper proxies mean faster breakthroughs, ethics baked via on-chain consent.
@BioProtocol ties it: $BIO stakes fuel BioXP for early access, veBIO locks amplify yields and voice. veBIO + XP decay force rotations, micro-tranches cut risk on milestones.
Playbook: Ladder $BIO now, farm XP in 14d windows, vet for replication gates and LIMS trails. Route to gut cohorts for quick signals, canine trials for long health bets.
12m view: Tighter $BIO float as BioAgents rack preclinical wins, DeSci compounding from data to cures.
Stacking bio yet or watching from sidelines?
#DeSci #BioProtocol $BIO
1,733
11
本页面内容由第三方提供。除非另有说明，欧易不是所引用文章的作者，也不对此类材料主张任何版权。该内容仅供参考，并不代表欧易观点，不作为任何形式的认可，也不应被视为投资建议或购买或出售数字资产的招揽。在使用生成式人工智能提供摘要或其他信息的情况下，此类人工智能生成的内容可能不准确或不一致。请阅读链接文章，了解更多详情和信息。欧易不对第三方网站上的内容负责。包含稳定币、NFTs 等在内的数字资产涉及较高程度的风险，其价值可能会产生较大波动。请根据自身财务状况，仔细考虑交易或持有数字资产是否适合您。